Pharmacotherapy of Alcohol Dependence: Treatment Readiness and Compliance Barriers

Abstract

Pharmacological treatments for alcohol use disorders have proven efficacy. However, only a minority of treated individuals receive pharmacotherapy. Moreover, in the majority of cases, treatment duration is too short and does not follow recommendations of guidelines. A number of barriers have been identified that are related to the poor adoption of pharmacotherapy for alcohol use disorders including characteristics of the system (e.g., lack of advocacy or treatment services, poor reimbursement for treatment), provider-based barriers (e.g., lack of knowledge or confidence, reluctance to prescribe pharmacotherapy), and patient characteristics (e.g., no interest in pharmacotherapy, poor access to care, fear of side-effects or stigmatization). Studies have tried to improve availability and adherence of pharmacological treatment of AUD. Patients’ attitudes towards pharmacological treatment have not been sufficiently investigated which might help to improve adoption.

Original languageEnglish
Title of host publicationNeuroPsychopharmacotherapy
Number of pages11
PublisherSpringer International Publishing
Publication date01.01.2022
Pages4497-4507
ISBN (Print)9783030620585
ISBN (Electronic)9783030620592
DOIs
Publication statusPublished - 01.01.2022

Research Areas and Centers

  • Academic Focus: Center for Brain, Behavior and Metabolism (CBBM)

DFG Research Classification Scheme

  • 206-10 Clinical Psychiatry, Psychotherapy amd Paediatric and Juvenile Psychiatrie

Cite this